Fitness for 5 genes in Pontibacter actiniarum KMM 6156, DSM 19842

Add gene:

Number of genes on each side:  

Top 30 experiments (either direction), sorted by average fitness

Or view all 112 experiments or choose conditions or try the comparative fitness browser

500 ntCA264_03815 and CA264_03820 are separated by 216 nucleotidesCA264_03820 and CA264_03825 are separated by 137 nucleotidesCA264_03825 and CA264_03830 are separated by 50 nucleotidesCA264_03830 and CA264_03835 are separated by 50 nucleotides CA264_03815: CA264_03815 - peptidoglycan-binding protein, at 891,768 to 892,748 _03815 CA264_03820: CA264_03820 - ketoacyl-ACP synthase III, at 892,965 to 893,963 _03820 CA264_03825: CA264_03825 - phosphate acyltransferase PlsX, at 894,101 to 895,042 _03825 CA264_03830: CA264_03830 - 50S ribosomal protein L32, at 895,093 to 895,290 _03830 CA264_03835: CA264_03835 - hypothetical protein, at 895,341 to 895,886 _03835
Group Condition CA264_03815 CA264_03820 CA264_03825 CA264_03830 CA264_03835
stress m.b. Dimethyl Sulfoxide 10 vol% -5.5 N.D. N.D. N.D. -1.0
stress m.b. Ceftazidime 0.001 mg/ml -5.7 N.D. N.D. N.D. +0.0
stress m.b. Ceftazidime 0.001 mg/ml -4.9 N.D. N.D. N.D. -0.4
stress m.b. Lomefloxacin 0.002 mM -4.8 N.D. N.D. N.D. -0.4
stress m.b. Ceftazidime 0.0005 mg/ml -4.7 N.D. N.D. N.D. -0.4
stress m.b. Dimethyl Sulfoxide 7.5 vol% -4.6 N.D. N.D. N.D. -0.5
stress m.b. Carbenicillin 0.0004 mg/ml -4.4 N.D. N.D. N.D. -0.6
stress m.b. Cephalothin 0.005 mg/ml -5.1 N.D. N.D. N.D. +0.1
stress m.b. Nalidixic 0.008 mg/ml -4.6 N.D. N.D. N.D. -0.3
stress m.b. Carbenicillin 0.0015 mg/ml -5.3 N.D. N.D. N.D. +0.4
stress m.b. Carbenicillin 0.0004 mg/ml -4.5 N.D. N.D. N.D. -0.3
stress m.b. Nalidixic 0.016 mg/ml -3.9 N.D. N.D. N.D. -0.8
stress m.b. Dimethyl Sulfoxide 10 vol% -3.9 N.D. N.D. N.D. -0.6
stress m.b. Carbenicillin 0.0015 mg/ml -5.0 N.D. N.D. N.D. +0.6
stress m.b. Thallium(I) acetate 0.001 mg/ml -1.7 N.D. N.D. N.D. -2.5
stress m.b. Vancomycin 0.016 mg/ml -4.3 N.D. N.D. N.D. +0.1
stress m.b. Chlorite 0.08 mM -4.0 N.D. N.D. N.D. -0.2
stress m.b. Nalidixic 0.016 mg/ml -4.0 N.D. N.D. N.D. -0.1
stress m.b. Nalidixic 0.008 mg/ml -3.7 N.D. N.D. N.D. -0.4
stress m.b. Cisplatin 0.025 mg/ml -3.2 N.D. N.D. N.D. -0.8
stress m.b. Lomefloxacin 0.002 mM -3.3 N.D. N.D. N.D. -0.5
stress m.b. Vancomycin 0.008 mg/ml -3.9 N.D. N.D. N.D. +0.2
stress m.b. Ceftazidime 0.0005 mg/ml -4.0 N.D. N.D. N.D. +0.4
stress m.b. Chloride 750 mM -3.7 N.D. N.D. N.D. +0.2
stress m.b. Cephalothin 0.005 mg/ml -3.5 N.D. N.D. N.D. +0.2
stress m.b. copper (II) chloride 0.16 mM -3.3 N.D. N.D. N.D. +0.3
stress m.b. A22 0.04 mg/ml -3.2 N.D. N.D. N.D. +0.4
stress m.b. Vancomycin 0.016 mg/ml -3.4 N.D. N.D. N.D. +0.6
stress m.b. Chlorite 0.08 mM -3.1 N.D. N.D. N.D. +0.5
stress m.b. A22 0.04 mg/ml -2.7 N.D. N.D. N.D. +0.6
remove
CA264_03815
plot		 remove
CA264_03820
plot		 remove
CA264_03825		 remove
CA264_03830
plot		 remove
CA264_03835
plot